These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22878095)

  • 81. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.
    Wu X; Lee EM; Hammack C; Robotham JM; Basu M; Lang J; Brinton MA; Tang H
    J Virol; 2014 Aug; 88(15):8433-44. PubMed ID: 24829338
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hepatitis C virus relies on lipoproteins for its life cycle.
    Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T
    World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.
    Yin P; Zhang L; Ye F; Deng Y; Lu S; Li YP; Zhang L; Tan W
    Sci Rep; 2017 Jun; 7(1):3976. PubMed ID: 28638089
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
    Khan AG; Whidby J; Miller MT; Scarborough H; Zatorski AV; Cygan A; Price AA; Yost SA; Bohannon CD; Jacob J; Grakoui A; Marcotrigiano J
    Nature; 2014 May; 509(7500):381-4. PubMed ID: 24553139
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.
    Haid S; Pietschmann T; Pécheur EI
    J Biol Chem; 2009 Jun; 284(26):17657-67. PubMed ID: 19411248
    [TBL] [Abstract][Full Text] [Related]  

  • 88. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
    Lupberger J; Zeisel MB; Xiao F; Thumann C; Fofana I; Zona L; Davis C; Mee CJ; Turek M; Gorke S; Royer C; Fischer B; Zahid MN; Lavillette D; Fresquet J; Cosset FL; Rothenberg SM; Pietschmann T; Patel AH; Pessaux P; Doffoël M; Raffelsberger W; Poch O; McKeating JA; Brino L; Baumert TF
    Nat Med; 2011 May; 17(5):589-95. PubMed ID: 21516087
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hepatitis C Virus Infection of Cultured Cells and Primary Human Hepatocytes.
    Lowey B; Li Q
    Curr Protoc Cell Biol; 2018 Sep; 80(1):e54. PubMed ID: 30058773
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HCV and host lipids: an intimate connection.
    Schaefer EA; Chung RT
    Semin Liver Dis; 2013 Nov; 33(4):358-68. PubMed ID: 24222093
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry.
    Kim S; Ishida H; Yamane D; Yi M; Swinney DC; Foung S; Lemon SM
    J Virol; 2013 Apr; 87(8):4214-24. PubMed ID: 23365451
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
    J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The HCV life cycle: in vitro tissue culture systems and therapeutic targets.
    Gerold G; Pietschmann T
    Dig Dis; 2014; 32(5):525-37. PubMed ID: 25034285
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
    Ghosh S; Kaplan KJ; Schrum LW; Bonkovsky HL
    Int Rev Cell Mol Biol; 2013; 302():279-319. PubMed ID: 23351713
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
    Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
    Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Role of lipid metabolism in hepatitis C virus assembly and entry.
    Popescu CI; Dubuisson J
    Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry.
    Gerold G; Meissner F; Bruening J; Welsch K; Perin PM; Baumert TF; Vondran FW; Kaderali L; Marcotrigiano J; Khan AG; Mann M; Rice CM; Pietschmann T
    Cell Rep; 2015 Aug; 12(5):864-78. PubMed ID: 26212323
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The role of PTEN - HCV core interaction in hepatitis C virus replication.
    Wu Q; Li Z; Mellor P; Zhou Y; Anderson DH; Liu Q
    Sci Rep; 2017 Jun; 7(1):3695. PubMed ID: 28623358
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy.
    Ploen D; Hildt E
    World J Gastroenterol; 2015 Jul; 21(28):8492-507. PubMed ID: 26229393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.